U.S. FDA Renews DILIsym® Software Licenses for 7th Year

Predicting DILI risk supports informed decision-making regarding drug evaluations and approvals

...

Related Keywords

Linkedinx Youtube , Bretta Howell , Paulb Watkins , Quantitative Systems Pharmacology Solutions At Simulations , Nasdaq , Dili Sim Initiative , Simulations Plus Inc , Exchange Commission , Simulations Plus , Scientific Advisory Board , Quantitative Systems Pharmacology Solutions , Markets ,